These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

830 related articles for article (PubMed ID: 7994815)

  • 1. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
    Fananapazir L; Epstein ND; Curiel RV; Panza JA; Tripodi D; McAreavey D
    Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy.
    Fananapazir L; Cannon RO; Tripodi D; Panza JA
    Circulation; 1992 Jun; 85(6):2149-61. PubMed ID: 1350522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of ventricular septal morphology in the effectiveness of dual chamber pacing in hypertrophic obstructive cardiomyopathy.
    Dimitrow PP; Grodecki J; Bacior B; Dudek D; Legutko J; Jaszcz KK; Dubiel JS
    Pacing Clin Electrophysiol; 2000 Sep; 23(9):1324-9. PubMed ID: 11025886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy.
    Lucon A; Palud L; Pavin D; Donal E; Behar N; Leclercq C; Mabo P; Daubert JC
    Arch Cardiovasc Dis; 2013; 106(6-7):373-81. PubMed ID: 23806305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of dual-chamber pacing with periodic echocardiographic evaluation of optimal atrioventricular delay in patients with hypertrophic cardiomyopathy >50 years of age.
    Topilski I; Sherez J; Keren G; Copperman I
    Am J Cardiol; 2006 Jun; 97(12):1769-75. PubMed ID: 16765132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual chamber pacemaker therapy for mid-cavity obstructive hypertrophic cardiomyopathy.
    Begley D; Mohiddin S; Fananapazir L
    Pacing Clin Electrophysiol; 2001 Nov; 24(11):1639-44. PubMed ID: 11816633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late benefits of dual-chamber pacing in obstructive hypertrophic cardiomyopathy: a 10-year follow-up study.
    Galve E; Sambola A; Saldaña G; Quispe I; Nieto E; Diaz A; Evangelista A; Candell-Riera J
    Heart; 2010 Mar; 96(5):352-6. PubMed ID: 19482844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial.
    Nishimura RA; Trusty JM; Hayes DL; Ilstrup DM; Larson DR; Hayes SN; Allison TG; Tajik AJ
    J Am Coll Cardiol; 1997 Feb; 29(2):435-41. PubMed ID: 9015001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy.
    Minami Y; Kajimoto K; Kawana M; Hagiwara N; Sherrid MV
    Int J Cardiol; 2010 May; 141(2):195-7. PubMed ID: 19097655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual chamber pacing in hypertrophic cardiomyopathy: long-term effects on diastolic function.
    Betocchi S; Elliott PM; Briguori C; Virdee M; Losi MA; Matsumura Y; Miranda M; McKenna WJ; Chiariello M
    Pacing Clin Electrophysiol; 2002 Oct; 25(10):1433-40. PubMed ID: 12418740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical response to exercise in asymptomatic hypertrophic cardiomyopathy: a new description of outflow tract obstruction dynamics.
    Lafitte S; Reant P; Touche C; Pillois X; Dijos M; Arsac F; Peyrou J; Montaudon M; Ritter P; Roudaut R; Demaria A
    J Am Coll Cardiol; 2013 Aug; 62(9):842-50. PubMed ID: 23810875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered cardiac hemodynamic and electrical state in normal sinus rhythm after chronic dual-chamber pacing for relief of left ventricular outflow obstruction in hypertrophic cardiomyopathy.
    McAreavey D; Fananapazir L
    Am J Cardiol; 1992 Sep; 70(6):651-6. PubMed ID: 1510015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dual-chamber pacing for pediatric patients with hypertrophic obstructive cardiomyopathy.
    Rishi F; Hulse JE; Auld DO; McRae G; Kaltman J; Kanter K; Williams W; Campbell RM
    J Am Coll Cardiol; 1997 Mar; 29(4):734-40. PubMed ID: 9091517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.
    Seggewiss H; Gleichmann U; Faber L; Fassbender D; Schmidt HK; Strick S
    J Am Coll Cardiol; 1998 Feb; 31(2):252-8. PubMed ID: 9462563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-chamber pacing in hypertrophic obstructive cardiomyopathy: a comparison of acute and chronic effects.
    Sakai Y; Kawakami Y; Hirota Y; Ito T; Shimada S; Tokaji Y; Suwa M; Kawamura K; Morimoto T; Nishimoto Y; Sasaki S
    Jpn Circ J; 1999 Dec; 63(12):971-5. PubMed ID: 10614843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY).
    Maron BJ; Nishimura RA; McKenna WJ; Rakowski H; Josephson ME; Kieval RS
    Circulation; 1999 Jun; 99(22):2927-33. PubMed ID: 10359738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subacute and chronic effects of DDD pacing on left ventricular diastolic function in patients with non-obstructive hypertrophic cardiomyopathy.
    Watanabe K; Sekiya M; Ikeda S; Funada J; Suzuki J; Sueda S; Tsuruoka T
    Jpn Circ J; 2001 Apr; 65(4):283-8. PubMed ID: 11316124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy. Acute Doppler echocardiographic and catheterization hemodynamic study.
    Nishimura RA; Hayes DL; Ilstrup DM; Holmes DR; Tajik AJ
    J Am Coll Cardiol; 1996 Feb; 27(2):421-30. PubMed ID: 8557915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and design of the TRICHAMPION trial: Triple Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy Patients.
    Berruezo A; Linhart M; Auricchio A; Zamorano JL; Santamaria P; Borràs R; Burgos F; Brugada J
    J Interv Card Electrophysiol; 2018 Mar; 51(2):117-124. PubMed ID: 29397524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of dual-chamber pacing with nonsurgical septal reduction effect in patients with hypertrophic obstructive cardiomyopathy.
    Dimitrow PP; Podolec P; Grodecki J; Płazak W; Dudek D; Pieniazek P; Bacior B; Legutko J; Olszowska M; Kostkiewicz M; Kawecka-Jaszcz K; Tracz W; Dubiel JS
    Int J Cardiol; 2004 Mar; 94(1):31-4. PubMed ID: 14996471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.